These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3839607)

  • 21. The metabolism of human serum albumin in renal failure on conservative and dialysis therapy.
    Bianchi R; Mariani G; Toni MG; Carmassi F
    Am J Clin Nutr; 1978 Sep; 31(9):1615-26. PubMed ID: 685877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated plasma adenine nucleotide levels in chronic renal failure and their possible significance.
    Moss AH; Solomons CC; Alfrey AC
    Proc Clin Dial Transplant Forum; 1979; 9():184-8. PubMed ID: 399505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal insufficiency and hemostasis].
    Nieth H
    Thromb Diath Haemorrh; 1968; ():141-54. PubMed ID: 5726650
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.
    Trelewicz P; Grzeszczak W; Drabczyk R
    Int Urol Nephrol; 1994; 26(1):117-23. PubMed ID: 8026916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal changes in uremia.
    Bonomini V; Orsoni G; Stefoni S; Vangelista A
    Clin Nephrol; 1979 Jun; 11(6):275-80. PubMed ID: 477043
    [No Abstract]   [Full Text] [Related]  

  • 26. Interleukin-2 receptor levels in end-stage renal disease and transplant patients.
    Di Stefano R; Carmellini M; Zucchelli G; Clerico A; Masini S; D'Elia F; Fossati N; Ambrogi F; Mosca F
    Transplant Proc; 1990 Aug; 22(4):1863-4. PubMed ID: 2389462
    [No Abstract]   [Full Text] [Related]  

  • 27. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
    Mannucci PM; Valsecchi C; Bottasso B; D'Angelo A; Casati S; Ponticelli C
    Thromb Haemost; 1986 Feb; 55(1):31-3. PubMed ID: 3754658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
    McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
    Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low levels of the anticoagulant activity of protein C in patients with chronic renal insufficiency: an inhibitor of protein C is present in uremic plasma.
    Faioni EM; Franchi F; Krachmalnicoff A; Valsecchi C; Viganò GL; Remuzzi G; Mannucci PM
    Thromb Haemost; 1991 Oct; 66(4):420-5. PubMed ID: 1796390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease.
    Koenig KG; Lindberg JS; Zerwekh JE; Padalino PK; Cushner HM; Copley JB
    Kidney Int; 1992 Jan; 41(1):161-5. PubMed ID: 1593853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum copper and manganese serum concentrations in uremia].
    Börner H; Mehnert E; Bruhn P; Hudec R
    Z Urol Nephrol; 1983 Aug; 76(8):544-8. PubMed ID: 6356702
    [No Abstract]   [Full Text] [Related]  

  • 32. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
    Attman PO; Alaupovic P
    Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure.
    Lipshultz SE; Somers MJ; Lipsitz SR; Colan SD; Jabs K; Rifai N
    Pediatrics; 2003 Jul; 112(1 Pt 1):79-86. PubMed ID: 12837871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.
    Vlachoyannis J; Schoeppe W
    Klin Wochenschr; 1982 Jul; 60(13):651-7. PubMed ID: 6289001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uremia.
    Hällgren R; Engström-Laurent A; Nisbeth U
    Nephron; 1987; 46(2):150-4. PubMed ID: 3299122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma histamine in patients with chronic renal failure and nephrotic syndrome.
    Gill DS; Fonseca VA; Barradas MA; Balliod R; Moorhead JF; Dandona P
    J Clin Pathol; 1991 Mar; 44(3):243-5. PubMed ID: 2013627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of initiation of uremia therapy: where is the science?
    Ifudu O
    Int J Artif Organs; 1997 Nov; 20(11):601-2. PubMed ID: 9464868
    [No Abstract]   [Full Text] [Related]  

  • 39. An increased apo A-IV serum concentration of patients with chronic renal failure on hemodialysis.
    Seishima M; Muto Y
    Clin Chim Acta; 1987 Aug; 167(3):303-11. PubMed ID: 3621614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodialysis and plasma amino acid composition in chronic renal failure.
    Gulyassy PF; Peters JH; Lin SC; Ryan PM
    Am J Clin Nutr; 1968 Jun; 21(6):565-73. PubMed ID: 5666633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.